Human medicines European public assessment report (EPAR): Gavreto, pralsetinib, Date of authorisation: 18/11/2021, Revision: 8, Status: Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 17 January 2025 - 16:15

Human medicines European public assessment report (EPAR): Gavreto, pralsetinib, Date of authorisation: 18/11/2021, Revision: 8, Status: Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/gavreto

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters